7-Nitroindazole: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{ | {{DISPLAYTITLE:7-Nitroindazole}} | ||
}} | |||
== 7-Nitroindazole == | |||
[[File:7-Nitroindazole.svg|thumb|right|Chemical structure of 7-Nitroindazole]] | |||
7-Nitroindazole is a chemical compound that belongs to the class of [[indazole]] derivatives. It is primarily known for its role as a selective inhibitor of the enzyme [[nitric oxide synthase]] (NOS), particularly the neuronal form (nNOS). This compound has been studied for its potential therapeutic effects in various neurological disorders due to its ability to modulate nitric oxide (NO) production in the brain. | |||
==Chemical Properties== | == Chemical Properties == | ||
7-Nitroindazole is | 7-Nitroindazole is characterized by the presence of a nitro group at the 7-position of the indazole ring. This structural modification is crucial for its activity as a NOS inhibitor. The chemical formula of 7-Nitroindazole is C7H5N3O2, and it has a molecular weight of 163.13 g/mol. | ||
==Mechanism of Action== | == Mechanism of Action == | ||
7-Nitroindazole | The primary mechanism of action of 7-Nitroindazole involves the inhibition of neuronal nitric oxide synthase (nNOS). By inhibiting nNOS, 7-Nitroindazole reduces the production of nitric oxide, a signaling molecule that plays a significant role in various physiological and pathological processes, including [[neurotransmission]], [[vasodilation]], and [[inflammation]]. | ||
==Applications | == Therapeutic Applications == | ||
7-Nitroindazole | 7-Nitroindazole has been investigated for its potential use in treating neurological conditions such as [[stroke]], [[Parkinson's disease]], and [[Alzheimer's disease]]. Its ability to modulate nitric oxide levels in the brain makes it a candidate for neuroprotection and the reduction of oxidative stress. | ||
== | == Research and Development == | ||
Research | Research on 7-Nitroindazole has focused on its pharmacological effects in animal models of neurological diseases. Studies have shown that it can reduce neuronal damage and improve outcomes in models of ischemic stroke and neurodegenerative diseases. However, further research is needed to fully understand its efficacy and safety in humans. | ||
== | == Related Compounds == | ||
7-Nitroindazole is part of a broader class of indazole derivatives that have been studied for their biological activities. Other related compounds include various indazole-based inhibitors of nitric oxide synthase and other enzymes involved in inflammatory and neurodegenerative pathways. | |||
== | == See Also == | ||
* [[Nitric oxide synthase]] | * [[Nitric oxide synthase]] | ||
* [[Neuroprotection]] | * [[Neuroprotection]] | ||
* [[Indazole]] | * [[Indazole]] | ||
* [[Neurodegenerative disease]] | |||
== Related pages == | |||
* [[Nitric oxide]] | |||
* [[Enzyme inhibitor]] | |||
* [[Neurotransmitter]] | |||
[[Category:Indazoles]] | [[Category:Indazoles]] | ||
[[Category:Nitric oxide synthase inhibitors]] | |||
[[Category:Neuropharmacology]] | [[Category:Neuropharmacology]] | ||
Latest revision as of 11:04, 15 February 2025
7-Nitroindazole[edit]
7-Nitroindazole is a chemical compound that belongs to the class of indazole derivatives. It is primarily known for its role as a selective inhibitor of the enzyme nitric oxide synthase (NOS), particularly the neuronal form (nNOS). This compound has been studied for its potential therapeutic effects in various neurological disorders due to its ability to modulate nitric oxide (NO) production in the brain.
Chemical Properties[edit]
7-Nitroindazole is characterized by the presence of a nitro group at the 7-position of the indazole ring. This structural modification is crucial for its activity as a NOS inhibitor. The chemical formula of 7-Nitroindazole is C7H5N3O2, and it has a molecular weight of 163.13 g/mol.
Mechanism of Action[edit]
The primary mechanism of action of 7-Nitroindazole involves the inhibition of neuronal nitric oxide synthase (nNOS). By inhibiting nNOS, 7-Nitroindazole reduces the production of nitric oxide, a signaling molecule that plays a significant role in various physiological and pathological processes, including neurotransmission, vasodilation, and inflammation.
Therapeutic Applications[edit]
7-Nitroindazole has been investigated for its potential use in treating neurological conditions such as stroke, Parkinson's disease, and Alzheimer's disease. Its ability to modulate nitric oxide levels in the brain makes it a candidate for neuroprotection and the reduction of oxidative stress.
Research and Development[edit]
Research on 7-Nitroindazole has focused on its pharmacological effects in animal models of neurological diseases. Studies have shown that it can reduce neuronal damage and improve outcomes in models of ischemic stroke and neurodegenerative diseases. However, further research is needed to fully understand its efficacy and safety in humans.
Related Compounds[edit]
7-Nitroindazole is part of a broader class of indazole derivatives that have been studied for their biological activities. Other related compounds include various indazole-based inhibitors of nitric oxide synthase and other enzymes involved in inflammatory and neurodegenerative pathways.
